MediSapiens is excited to join the Team Finland visit to Boston and Cambridge on 11 – 15 November 2019. The visit gives life science and healthcare companies an opportunity to explore the new business and R&D partnership opportunities in the United States pharmaceutical field. MediSapiens will highlight its groundbreaking work in the effective use of large cohorts of genomic and phenotype data with its clients in pharma, biobanking and population scale programs.
The Boston and Cambridge area is one of the most important life science innovation hubs of the country, making it an extremely interesting area to visit for MediSapiens and the whole Team Finland delegation. During the visit, the delegates will have an opportunity to meet with experts and potential partners in the R&D centers of global pharmaceuticals, including companies like Pfizer, Merck & Co., Inc. and Biogen.
Team Finland is a network of public sector actors providing internationalization services and aims to provide businesses with a smooth service chain, ranging from advice services to financing. MediSapiens team is looking forward to attending the visit and for the interesting meetings with potential partners and customers!